Fig. 3

sALCAM serum concentration at baseline and decrease of HOMA-IR (ΔHOMA-IR). Subjects who showed a higher decrease of HOMA-IR had higher serum concentration of sALCAM at baseline. Data are shown as quartiles of the reduction of HOMA-IR (ΔHOMA-IR) and mean levels of sALCAM at baseline with error bars showing SE. Wilcoxon signed-rank test was applied for comparing single point measurements. *P < 0.05